Skip to Content

GAO Issues Report on Characteristics of 340B Hospitals

July 20, 2018

The Government Accountability Office (GAO) July 18 released a report on the characteristics of hospitals that participate in the 340B Drug Pricing Program. The report compares certain characteristics of 340B and non-340B hospitals and describes how the characteristics of these hospitals changed after some states expanded Medicaid coverage.

House Energy and Commerce Oversight Subcommittee Holds Hearing on How to Improve Health Care Cost Transparency

July 20, 2018

The House Energy and Commerce Subcommittee on Oversight and Investigations July 17 held a hearing titled, “Examining State Efforts to Improve Transparency of Health Care Costs for Consumers.” The hearing focused on state laws and policies to improve health care costs, with price transparency being a central theme throughout the hearing.

Court Dismisses 340B Lawsuit; Case to be Refiled

July 20, 2018

The U.S. Court of Appeals for the District of Columbia July 17 dismissed a lawsuit filed by the AAMC, the American Hospital Association, and America’s Essential Hospitals, and three hospital plaintiffs (Henry Ford Health System, Eastern Maine Healthcare Systems, and Park Ridge Health), which challenged the reductions to certain Medicare Part B drugs for 340B disproportionate share hospitals under the Medicare Outpatient Prospective Payment System (OPPS). The OPPS final rule reduced payments for non pass-through drugs from average sales price (ASP) plus 6% to ASP minus 22.5% beginning Jan. 1 [see Washington Highlights, Nov. 3, 2017].

On Patient Care

Testimony and Correspondence